Scarica l'app Stockscreener
126.72
0.13%
-0.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$126.88
Aprire:
$127.31
Volume 24 ore:
572.16K
Relative Volume:
0.88
Capitalizzazione di mercato:
$5.60B
Reddito:
$3.04B
Utile/perdita netta:
$191.94M
Rapporto P/E:
29.83
EPS:
4.2479
Flusso di cassa netto:
$396.44M
1 W Prestazione:
+5.76%
1M Prestazione:
+18.43%
6M Prestazione:
+5.66%
1 anno Prestazione:
-29.65%
Intervallo 1D:
$125.91
$128.83
Intervallo di 1 settimana:
$124.78
$136.95
Portata 52W:
$102.58
$185.94
Teleflex Incorporated Stock (TFX) Company Profile
Nome
Teleflex Incorporated
Settore
Industria
Telefono
610-225-6800
Indirizzo
550 E SWEDESFORD RD, WAYNE, PA
Confronta TFX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
126.72 | 5.61B | 3.04B | 191.94M | 396.44M | 4.2479 |
|
ISRG
Intuitive Surgical Inc
|
559.52 | 192.25B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.09 | 57.34B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.19 | 38.71B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
253.07 | 36.82B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
271.86 | 19.25B | 2.96B | 487.70M | 344.00M | 6.6758 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Downgrade | Needham | Buy → Hold |
| 2023-05-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-29 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-09 | Iniziato | BofA Securities | Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Ripresa | Raymond James | Outperform |
| 2021-07-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Reiterato | Needham | Buy |
| 2020-11-02 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Wells Fargo | Outperform |
| 2019-04-24 | Downgrade | Needham | Strong Buy → Buy |
| 2019-02-22 | Reiterato | Needham | Strong Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-09-10 | Aggiornamento | Needham | Buy → Strong Buy |
| 2018-08-03 | Reiterato | Needham | Buy |
| 2018-05-14 | Reiterato | Needham | Buy |
| 2018-05-04 | Reiterato | Needham | Buy |
| 2018-04-04 | Iniziato | Goldman | Neutral |
| 2017-11-10 | Ripresa | Piper Jaffray | Overweight |
| 2017-11-03 | Reiterato | Needham | Buy |
| 2017-09-08 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Reiterato | Needham | Buy |
| 2017-03-07 | Iniziato | Needham | Buy |
| 2017-01-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-07-12 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Mostra tutto
Teleflex Incorporated Borsa (TFX) Ultime notizie
Teleflex sells acute care and urology businesses for $2.03 billion - Today's Medical Developments
Teleflex to sell acute care, interventional urology, OEM units for $2.03B - MSN
Medtech in a Minute: Teleflex Divestment & More - Medical Device and Diagnostic industry
Teleflex (NYSE:TFX) Shares Rise After Vascular Acquisition News - Kalkine Media
Wayne’s Teleflex to Sell Three Business Divisions in Two Separate Deals - VISTA.Today
Wells Fargo Maintains Teleflex (TFX) Equal-Weight Recommendation - Nasdaq
Teleflex: Selling, But How Much? (NYSE:TFX) - Seeking Alpha
Teleflex (TFX) Receives Updated Analyst Rating from Wells Fargo - GuruFocus
Teleflex to sell 3 medical technology divisions for a combined $2B - The Business Journals
Teleflex Sells Acute Care, Urology, and Medtech OEM Businesses in $2B Deal - PlasticsToday
Teleflex inks deals to sell 3 businesses for $2B - MedTech Dive
Teleflex to sell trio of business lines in deals totalling over $2bn - Yahoo Finance
US: Montagu and Kohlberg to carve out Teleflex Medical OEM for US$1.5bn - Investors in Healthcare
Teleflex stock price target raised to $139 from $114 at Wells Fargo - Investing.com UK
Teleflex stock rating maintained by Citizens on NewCo sale - Investing.com Australia
Teleflex Sells Acute Care, Interventional Urology, OEM Businesses For $2.03Bln - Nasdaq
Teleflex Stock (+9.6%) : Portfolio Optimization Ignites Strategic Re-rating - Trefis
Teleflex stock holds steady as Needham maintains rating amid asset sales By Investing.com - Investing.com South Africa
Q3 Earnings Outperformers: Teleflex (NYSE:TFX) And The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
Teleflex’s Latest Moves: What’s Next for TFX Stock? - StocksToTrade
Teleflex Incorporated (TFX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Teleflex stock holds steady as Needham maintains rating amid asset sales - Investing.com Nigeria
Teleflex Announces $2.03 Billion Business Sale Agreements - TipRanks
Teleflex announces $2.03 billion business sale agreements - MSN
Teleflex Inc enters equity purchase agreement with Lotus US BidcoSEC filing - marketscreener.com
Teleflex Stock Gains Momentum Amid Jefferies Global Presentation - StocksToTrade
Teleflex Soars on Strategic Divestitures and $1 Billion Share Buyback Plan - Markets Financial Content
Teleflex Divests Businesses for $2.03B, Announces $1B BuybackStock Up 11%News and Statistics - IndexBox
Why Are Teleflex (TFX) Shares Soaring Today - Finviz
Teleflex stock soars after $2.03B sale of business units and $1B buyback By Investing.com - Investing.com South Africa
Teleflex stock soars after $2.03B sale of business units and $1B buyback - Investing.com UK
Teleflex To Divest Multiple Units In Deals Topping $2B - Law360
Teleflex Medical to Sell for $1.5B - Medical Device and Diagnostic industry
Intersurgical Limited agreed to acquire Acute Care and Interventional Urology businesses of Teleflex for approximately $530 million. - marketscreener.com
Teleflex: Opportunity Amidst Market Challenges? - timothysykes.com
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion - citybiz
Teleflex Stock (TFX) Soars on a $2B Deal - TipRanks
Teleflex inks $2B in divestment deals for OEM, urology and acute care units - Fierce Biotech
Teleflex Medical OEM is getting sold to private equity firms - Medical Design & Outsourcing
Teleflex Scheduled for Key Presentation at Jefferies Conference - timothysykes.com
Medical device maker Teleflex to divest three units for $2.03 billion - Reuters
Teleflex will sell Acute Care, Urology, OEM businesses for $2.03B - MassDevice
Teleflex selling 3 business units for $2.03B - BioWorld MedTech
Montagu and Kohlberg to acquire Teleflex Medical OEM for $1.5 billion By Investing.com - Investing.com South Africa
Montagu and Kohlberg to acquire Teleflex Medical OEM for $1.5 billion - Investing.com
Teleflex to Sell Acute Care, Urology, OEM Businesses for $2B - Medical Product Outsourcing
Montagu and Kohlberg to acquire Teleflex Medical OEM from Teleflex in a $1.5bn carve-out - pehub.com
Teleflex to Sell 3 Businesses for $2.03 Billion - marketscreener.com
Teleflex To Divest Acute Care, Interventional Urology, OEM Businesses For $2.03 Bln - Nasdaq
Teleflex to Sell Acute Care, Interventional Urology, OEM Businesses for $2.03 Billion in Cash - marketscreener.com
Teleflex Incorporated Azioni (TFX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.98%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):